![HBX-19818 - Deubiquitinase 抑制劑 - 生命科學試劑 - MedChemExpress_第1頁](http://file4.renrendoc.com/view/b2b8ddf05f4cfcb6278c6f37f24ec682/b2b8ddf05f4cfcb6278c6f37f24ec6821.gif)
![HBX-19818 - Deubiquitinase 抑制劑 - 生命科學試劑 - MedChemExpress_第2頁](http://file4.renrendoc.com/view/b2b8ddf05f4cfcb6278c6f37f24ec682/b2b8ddf05f4cfcb6278c6f37f24ec6822.gif)
![HBX-19818 - Deubiquitinase 抑制劑 - 生命科學試劑 - MedChemExpress_第3頁](http://file4.renrendoc.com/view/b2b8ddf05f4cfcb6278c6f37f24ec682/b2b8ddf05f4cfcb6278c6f37f24ec6823.gif)
![HBX-19818 - Deubiquitinase 抑制劑 - 生命科學試劑 - MedChemExpress_第4頁](http://file4.renrendoc.com/view/b2b8ddf05f4cfcb6278c6f37f24ec682/b2b8ddf05f4cfcb6278c6f37f24ec6824.gif)
下載本文檔
版權說明:本文檔由用戶提供并上傳,收益歸屬內容提供方,若內容存在侵權,請進行舉報或認領
文檔簡介
1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEHBX 19818Cat. No.: HY-17540CAS No.: 1426944-49-1分式: CHClNO分量: 421.96作靶點: Deubiquitinase作通路: Cell Cycle/DNA Damage儲存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數據體外實驗 DMSO : 3.5 mg/mL (8.29 mM; Need ult
2、rasonic and warming)Mass Solvent1 mg 5 mg 10 mg Concentration制備儲備液1 mM 2.3699 mL 11.8495 mL 23.6989 mL5 mM 0.4740 mL 2.3699 mL 4.7398 mL10 mM - - -請根據產品在不同溶劑中的溶解度,選擇合適的溶劑配制儲備液,并請注意儲備液的保存式和期限。BIOLOGICAL ACTIVITY物活性 HBX 19818種泛素蛋特異性蛋酶 (USP7) 抑制劑,IC50 值為 28.1 M。IC50 & Target IC50: 28.1 M (USP7) 1體外研究HB
3、X 19818 is an inhibitor of USP7, with an IC50 of 28.1 M. HBX 19818 shows no effects on USP8, USP5,USP10, CYLD, UCH-L1, UCH-L3 or on SENP1, a SUMO protease, with IC50s of 200 M. HBX 19818selectively inhibits USP7 with IC50 of -6 M in in human cancer cells. In addition, HBX 19818 (1.5, 4, 12, 36,1/3 M
4、aster of Small Molecules 您邊的抑制劑師www.MedChemEor 100 M) inhibits USP7 deubiquitination of polyubiquitinated p53. HBX 19818 (30 M) also causessignificantly higher levels of Mdm2 polyubiquitinated forms in USP7-overproducing HEK293 cells than thosein DMSO-treated control cells. HBX 19818 inhibits HCT116
5、 proliferation in a dose-dependent manner, withan IC50 of -2 M 1.PROTOCOLKinase Assay 1 The ability of HBX 19818 and HBX 28,258 to inhibit a panel of deubiquitinating enzymes, including UCH-L3(13 pM), USP7 (100 pM), USP8 (1.36 nM), UCH-L1 (2.5 nM), USP5 (10 nM), USP20 (10 nM), and USP2(500 pM), is t
6、ested using the UbAMC substrate (300 nM). The potential effects of HBX 19818 and HBX28,258 are also tested on the enzymatic activities of SENP1 (80 pM), cathepsin-B (100 pM), and caspase-3(100 pM) using the SUMO1-AMC (750 nM), ZRR-AMC (3 M), and DEVD-AMC (250 nM) substrates,respectively. All enzymes
7、 are tested in USP7 reaction buffer (50 mM Tris-HCl pH 7.6, 0.5 mM EDTA, 5 mMDTT, 0.01% Triton X-100, and 0.05 mg/mL serum albumin), except for two enzymes, USP8 (same buffer butpH 8.8) and caspase-3 (100 mM HEPES pH 7.5, 10% sucrose, and 0.1% CHAPS). All enzymes are pre-incubated with DMSO or compo
8、unds (including HBX 19818) for 30 min at room temperature, and theenzymatic reaction is initiated by adding the substrate of interest. The reaction mixture is incubated at roomtemperature for 1 hr, and the reaction is stopped by adding acetic acid (100 mM). The reactions aremonitored using the PHERA
9、star 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Cell Assay 1 HCT116 cell proliferation is evaluated by incubating HCT116 cells for 30 min in culture medium containing 10M 5- bromo-2-deoxyuridine (BrdU), which is incorporated into the DNA of proli
10、ferating cells. Cells are thenharvested by trypsin treatment, collected by centrifugation, and the pellet is resuspended and incubated in70% ethanol for 30 min at 4C. After centrifugation and supernatant removal, DNA is denaturated byincubating it in 2 N HCl for 30 min at room temperature. The perce
11、ntage of BrdU-containing cells is thendetermined by flow cytometry, making it possible to quantify proliferating cells. Cell cycle is evaluated aftertreatment with HBX 19818 for 24 hr, followed by fixing detached cells and trypsinized cells in 70% ethanol for30 minutes at 4C. Cells are then incubate
12、d in PBS supplemented with 1% BSA, 0.5% Tween 20, 50 g/mLRNase A and 50 g/mL propidiumiodide for 30 minutes at 37C. Samples are analyzed on a FACSortfluorocytometer. The percentage of cells in the different phases of the cell cycle is calculated using Multicyclesoftware 1.MCE has not independently c
13、onfirmed the accuracy of these methods. They are for reference only.戶使本產品發(fā)表的科研獻 Cell Metab. 2019 May 7;29(5):1166-1181.e6. Nat Chem Biol. 2017 Dec;13(12):1207-1215. Nat Struct Mol Biol. 2016 Apr;23(4):270-7. Mol Cell Biol. 2015 Apr 1;35(7):1157-68. Dev Growth Differ. 2019 Jan 10.See more customer validations on HYPERLINK / www.MedChemE2/3 Master of Small Molecules 您邊的抑制劑師www.MedChemEREFERENCES1. Reverdy C, et al. Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme. Chem Biol. 2012 Apr 20;19(4):46
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯系上傳者。文件的所有權益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網頁內容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
- 4. 未經權益所有人同意不得將文件中的內容挪作商業(yè)或盈利用途。
- 5. 人人文庫網僅提供信息存儲空間,僅對用戶上傳內容的表現方式做保護處理,對用戶上傳分享的文檔內容本身不做任何修改或編輯,并不能對任何下載內容負責。
- 6. 下載文件中如有侵權或不適當內容,請與我們聯系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 藝術展覽設計師的空間布局與藝術呈現
- 年產100萬套轉椅配件及15萬套成品生產線項目可行性研究報告模板-立項拿地
- 2025年全球及中國自鎖平頭螺母行業(yè)頭部企業(yè)市場占有率及排名調研報告
- 2025-2030全球自由式風帆板行業(yè)調研及趨勢分析報告
- 2025-2030全球鈣鈦礦太陽光模擬器行業(yè)調研及趨勢分析報告
- 2025-2030全球生命科學服務行業(yè)調研及趨勢分析報告
- 2025-2030全球無人機測繪系統(tǒng)行業(yè)調研及趨勢分析報告
- 2025年全球及中國碳捕獲與利用技術行業(yè)頭部企業(yè)市場占有率及排名調研報告
- 2025-2030全球汽車空調電機行業(yè)調研及趨勢分析報告
- 2025年全球及中國家用前置過濾器行業(yè)頭部企業(yè)市場占有率及排名調研報告
- 二零二五版電力設施維修保養(yǎng)合同協議3篇
- 最經典凈水廠施工組織設計
- VDA6.3過程審核報告
- 2024-2030年中國并購基金行業(yè)發(fā)展前景預測及投資策略研究報告
- 2024年湖南商務職業(yè)技術學院單招職業(yè)適應性測試題庫帶答案
- 骨科手術中常被忽略的操作課件
- 《湖南師范大學》課件
- 2024年全國各地中考試題分類匯編:作文題目
- 2024年高壓電工操作證考試復習題庫及答案(共三套)
- 《糖拌西紅柿 》 教案()
- 彈性力學數值方法:解析法:彈性力學中的變分原理
評論
0/150
提交評論